Active Ingredient History

NOW
  • Now
Tobramycin, an aminoglycoside antibiotic obtained from cultures of Streptomyces tenebrarius, it is effective against gram-negative bacteria, especially the pseudomonas species. Tobramycin is used in combination with other antibiotics to treat urinary tract infections, gynecologic infections, peritonitis, endocarditis, pneumonia, bacteremia and sepsis, respiratory infections including those associated with cystic fibrosis, osteomyelitis, and diabetic foot and other soft-tissue infections. It acts primarily by disrupting protein synthesis, leading to altered cell membrane permeability, progressive disruption of the cell envelope, and eventual cell death. Tobramycin has in vitro activity against a wide range of gram-negative organisms including Pseudomonas aeruginosa. Tobramycin binds irreversibly to one of two aminoglycoside binding sites on the 30 S ribosomal subunit, inhibiting bacterial protein synthesis. Tobramycin may also destabilize bacterial memebrane by binding to 16 S 16 S r-RNA. An active transport mechanism for aminoglycoside uptake is necessary in the bacteria in order to attain a significant intracellular concentration of tobramycin. KITABIS PAK (co-packaging of tobramycin inhalation solution and PARI LC PLUS Reusable Nebulizer) is indicated for the management of cystic fibrosis in adults and pediatric patients 6 years of age and older with P. aeruginosa.   NCATS

  • SMILES: NC[C@H]1O[C@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H]2O)[C@H](N)C[C@@H]1O.NC[C@H]4O[C@H](O[C@@H]5[C@@H](N)C[C@@H](N)[C@H](O[C@H]6O[C@H](CO)[C@@H](O)[C@H](N)[C@H]6O)[C@H]5O)[C@H](N)C[C@@H]4O.OS(=O)(=O)O.OS(=O)(=O)O.OS(=O)(=O)O.OS(=O)(=O)O.OS(=O)(=O)O
  • InChIKey: NZKFUBQRAWPZJP-BXKLGIMVSA-N
  • Mol. Mass: 1425.44
  • ALogP: -6.3
  • ChEMBL Molecules:
More Chemistry

Drug Pricing (per unit)

United States

$0.1980 - $1795.0300

Australia

$3.0857 - $20.5989
More Pricing Detail

Note: This drug pricing data is preliminary, incomplete, and may contain errors.

Combination drugs

( tobramycin (nebcin), dexamethasone - other name: tobradex st )
| |
3'-deoxykanamycin b | 47663 | aktob | bethkis | bramitob | dexamethasone mixture with tobramycin | nebcin | nebicin | nebramycin | nebramycin 6 | nebramycin factir 6 | nebramycin factor 6 | nebramycin-faktor 6 | nebramycin vi | nebris | o-3-amino-3-deoxy-alpha-d-glucopyranosyl-(1-4)-o-(2,6-diamino-2,3,6-trideoxy-alpha-d-ribohexopyranosyl-(1-4))-2-deoxy-d-streptamine | obramycin | tobi | tobi podhaler | tobracin | tobracin (tn) | tobradex | tobradex st | tobradistin | tobralex | tobramaxin | tobramicin | tobramicina | tobramycetin | tobramycin | tobramycine | tobramycin sulfate | tobramycin sulfate (pharmacy bulk) | tobramycinum | tobravisc | tobrex | tobrex (tn) | tymbrineb | vantobra

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue